دوغ هيلتون عالم أحياء جزيئية أسترالي
Hilton, Douglas J.
Hilton, Douglas James, 1964-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Hilton, Douglas J. (Douglas James), 1964-
VIAF ID: 271147727 (Personal)
Permalink: http://viaf.org/viaf/271147727
Preferred Forms
4xx's: Alternate Name Forms (6)
Works
| Title | Sources |
|---|---|
| Colony-stimulating factors : molecular and cellular biology |
|
| Haemopedia: An Expression Atlas of Murine Hematopoietic Cells |
|
| Hematopoietic defects in the Ts1Cje mouse model of Down syndrome |
|
| Identification of a Siglec-F+ granulocyte-macrophage progenitor. |
|
| Identification of diploid platelet-forming cells prior to the emergence of polyploidy megakaryocyte in the mouse embryo |
|
| Ihstone H3 lysine 9 methylation is involved not only in maintaining epigenetic silencing, but is essential for setting up gene silencing |
|
| Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. |
|
| Leukemia inhibitory factor: a biological perspective. |
|
| LIF: a molecule with divergent actions on myeloid leukaemic cells and embryonic stem cells |
|
| LIF: lots of interesting functions |
|
| Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors. |
|
| Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. |
|
| Mechanism of crosstalk inhibition of IL-6 signaling in response to LPS and TNFα |
|
| Membrane-associated RING-CH (MARCH) proteins down-regulate cell surface expression of the interleukin-6 receptor alpha chain (IL6Rα) |
|
| Membrane budding is a major mechanism of in vivo platelet biogenesis |
|
| MiSTIC, an integrated platform for the analysis of heterogeneity in large tumour transcriptome datasets |
|
| Mouse prenatal platelet-forming lineages share a core transcriptional program but divergent dependence on MPL. |
|
| Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation |
|
| Murine cerberus homologue mCer-1: a candidate anterior patterning molecule |
|
| A mutation in the translation initiation codon of Gata-1 disrupts megakaryocyte maturation and causes thrombocytopenia |
|
| Mutational inhibition of c-Myb or p300 ameliorates treatment-induced thrombocytopenia |
|
| Mutations in tropomyosin 4 underlie a rare form of human macrothrombocytopenia |
|
| The Myb-p300-CREB axis modulates intestine homeostasis, radiosensitivity and tumorigenesis |
|
| The Negative Regulation of JAK/STAT Signaling |
|
| NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells |
|
| Novel roles for erythroid Ankyrin-1 revealed through an ENU-induced null mouse mutant |
|
| Polycomb repressive complex 2 (PRC2) restricts hematopoietic stem cell activity |
|
| Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1). |
|
| A preliminary molecular phylogeny of shield-bearer moths (Lepidoptera: Adeloidea: Heliozelidae) highlights rich undescribed diversity. |
|
| Probabilistic analysis of recessive mutagenesis screen strategies |
|
| Production of a human neutralizing monoclonal antibody and its crystal structure in complex with ectodomain 3 of the interleukin-13 receptor α1 |
|
| Proximal genomic localization of STAT1 binding and regulated transcriptional activity |
|
| The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism |
|
| Reduced Lymphocyte Longevity and Homeostatic Proliferation in Lamin B Receptor-Deficient Mice Results in Profound and Progressive Lymphopenia |
|
| Regulation of hematopoietic stem cells by their mature progeny |
|
| Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. |
|
| Regulation of multiple cytokine signalling pathways by SOCS3 is independent of SOCS2. |
|
| The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. |
|
| The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response |
|
| Saturation mutagenesis of the WSXWS motif of the erythropoietin receptor. |
|
| Setdb1-mediated H3K9 methylation is enriched on the inactive X and plays a role in its epigenetic silencing |
|
| SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities |
|
| Signaling by type I and II cytokine receptors: ten years after |
|
| SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivation |
|
| SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling. |
|
| SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation |
|
| The SOCS box: a tale of destruction and degradation |
|
| SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. |
|
| SOCS2 negatively regulates growth hormone action in vitro and in vivo |
|
| Socs3 maintains the specificity of biological responses to cytokine signals during granulocyte and macrophage differentiation |
|
| SOCS5 is expressed in primary B and T lymphoid cells but is dispensable for lymphocyte production and function |
|
| A somatic cell genetic system for dissecting hemopoietic cytokine signal transduction |
|
| STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver |
|
| Structural analysis of the gene encoding the murine interleukin-11 receptor alpha-chain and a related locus. |
|
| Structural characterization of a murine myeloid leukaemia inhibitory factor |
|
| The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability. |
|
| Suckling defect in mice lacking the soluble haemopoietin receptor NR6. |
|
| Suppressor of Cytokine Signaling-1 Attenuates the Duration of Interferon γ Signal Transductionin Vitroandin Vivo |
|
| Suppressor of cytokine signaling-1 is a critical regulator of interleukin-7-dependent CD8+ T cell differentiation. |
|
| Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects. |
|
| Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130 |
|
| Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling |
|
| Suppressors of cytokine signaling: Relevance to gastrointestinal function and disease |
|
| Synergistic effects on erythropoiesis, thrombopoiesis, and stem cell competitiveness in mice deficient in thrombopoietin and steel factor receptors |
|
| Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene |
|
| Tissue-specific induction of SOCS gene expression by PRL |
|
| The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells |
|
| Transcriptional profiling of eosinophil subsets in interleukin-5 transgenic mice. |
|
| Tribute to Donald Metcalf |
|
| Tyrosine residues in the granulocyte colony-stimulating factor (G-CSF) receptor mediate G-CSF-induced differentiation of murine myeloid leukemic (M1) cells. |
|
| Understanding the molecular regulation of eosinophil production: a basis for intervention in inflammatory disease |
|
| Why Australia needs a Medical Research Future Fund |
|
